Unique Strategies and Average Treatment Effects
Strategy Science · 27.08.2026
DOI: 10.1287/stsc.2025.0341 ↗Kurz gefasst
Fachartikel in der Zeitschrift Strategy Science, online erschienen am 27.08.2026. Verfasst von Jason Snyder und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 110 Literaturangaben.
Abstract (Originalsprache)
What explains the increasing disconnect between empirical strategy research and real-world strategy? Although empirical methods have evolved, notably in the use of techniques that support causal identification, we argue that empirical strategy’s focus on estimating well-identified average treatment effects from a population-level model of performance is fundamentally misaligned with the strategist’s need for firm-specific insights about how to build firm-specific models that guide strategic decision making. This misalignment poses a critical problem because strategic decisions are typically one-shot, nondiversifiable, and deeply interconnected with other firm-specific choices. Thus, strategists require localized, firm-specific models and estimates rather than population-level average treatment effects. Through an extended empirical example, this paper demonstrates the limits of strategy’s current approach of ever-more-precise identification and offers guidance about methodological approaches that can help bridge the relevance gap.
Zitieren
APA
Snyder, J., Wuebker, R., & Zenger, T. (2026). Unique Strategies and Average Treatment Effects. Strategy Science. https://doi.org/10.1287/stsc.2025.0341
Vancouver
Snyder J, Wuebker R, Zenger T. Unique Strategies and Average Treatment Effects. Strategy Science. 2026. doi:10.1287/stsc.2025.0341
BibTeX
@article{Snyder2026,
author = {Snyder, Jason and Wuebker, Robert and Zenger, Todd},
title = {Unique Strategies and Average Treatment Effects},
journal = {Strategy Science},
year = {2026},
doi = {10.1287/stsc.2025.0341}
}
EUVIMED